These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22356350)

  • 81. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis.
    DeWester J; Philpot EE; Westlund RE; Cook CK; Rickard KA
    Allergy Asthma Proc; 2003; 24(5):331-7. PubMed ID: 14619333
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study.
    Fifer S; Toh L; Barkate H; Aggarwal V; Borade D; Gordonsmith RH; Wu W; Morgan C; Young K
    Patient Prefer Adherence; 2023; 17():141-151. PubMed ID: 36687019
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
    Howland WC; Amar NJ; Wheeler W; Sacks H
    Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
    Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
    [TBL] [Abstract][Full Text] [Related]  

  • 85. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
    Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Relationship between systemic corticosteroid exposure and growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model.
    Daley-Yates PT; Richards DH
    Clin Ther; 2004 Nov; 26(11):1905-19. PubMed ID: 15639702
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells.
    Berger WE; Bachert C; Allara R; Koltun A; Kopietz F; Maus JG; D'Addio AD
    J Asthma Allergy; 2020; 13():187-192. PubMed ID: 32547111
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
    Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
    Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis.
    Géhanno P; Desfougeres JL
    Allergy; 1997 Apr; 52(4):445-50. PubMed ID: 9188929
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis.
    Weiler JM; Meltzer EO
    Ann Allergy Asthma Immunol; 1997 Oct; 79(4):327-32. PubMed ID: 9357378
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
    Kyrein HJ; Horak F; Nirnberger G; Rehn D
    Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Onset of therapeutic effect of fluticasone propionate aqueous nasal spray.
    Meltzer EO; Rickard KA; Westlund RE; Cook CK
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):286-91. PubMed ID: 11289326
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
    Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
    Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Retrospective study on fluticasone propionate aqueous nasal spray efficacy in patients with allergic rhinitis: evaluation of clinical and laboratory parameters.
    Ventura MT; Piccinni T; Matino MG; Giuliano G; Di Corato R; Di Napoli P; Tursi A
    Allergy; 2001 Jan; 56(1):29-34. PubMed ID: 11167349
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis.
    Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R
    J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.
    Meltzer EO; Andrews C; Journeay GE; Lim J; Prillaman BA; Garris C; Philpot E
    Ann Allergy Asthma Immunol; 2010 Apr; 104(4):331-8. PubMed ID: 20408344
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study.
    Bousquet J; Chanal I; Alquié MC; Charpin D; Didier A; Germouty J; Greillier P; Ickovic MH; Maria Y; Montané F
    Allergy; 1993 Jul; 48(5):327-33. PubMed ID: 8368459
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%.
    Meltzer EO; Garadi R; Laforce C; Chadwick SJ; Berger WE; Gross G; Edwards MR; Crenshaw K; Wall GM
    Allergy Asthma Proc; 2008; 29(6):659-68. PubMed ID: 19144261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.